Sanofi

Sanofi to buy Dynavax for US$2.2 billion to add shingles vaccine
December 24, 2025
[ad_1] [PARIS] Sanofi agreed to buy Dynavax Technologies for about US$2.2 billion to expand its vaccines business with a shot for hepatitis B and an experimental shingles inoculation.Sanofi will pay...
Sanofi to buy Vicebio for up to US$1.6 billion in vaccine push
July 22, 2025
[ad_1] The French drugmaker will pay US$1.15 billion upfront with a commitment for potential milestones worth as much as US$450 millionPublished Tue, Jul 22, 2025 · 03:40 PM[PARIS] Sanofi agreed...
Sanofi to buy US biopharma group Blueprint for up to US$9.5 billion
June 2, 2025
[ad_1] [PARIS] France’s Sanofi has agreed to buy US-based Blueprint Medicines Corporation for up to US$9.5 billion to boost its position in rare immunology diseases, in the biggest deal struck...
Sanofi plans 5 billion-euro buyback, sees higher profit growth
January 30, 2025
[ad_1] SANOFI said it will repurchase five billion euros (S$7 billion) of stock and grow profits more quickly this year as the drugmaker pivots away from consumer health to focus...
France seeks job guarantees from Sanofi over Doliprane painkiller production
October 14, 2024
[ad_1] Doliprane is France’s best-selling drug and news that it could be partially sold to a foreign investor has prompted political concernsThe French government needs guarantees from drugmaker Sanofi that...